A group of NUST MISIS's young scientists has presented a new therapeutic material based
on nanofibers made of polycaprolactone modified with a thin - film antibacterial composition and plasma components of human blood.
The team evaluated the market potential of several patented innovations before focusing
on nanofiber technology developed by Dr. Orlin Velev, a professor of chemical and biomolecular engineering.
Not exact matches
We obtained high - quality cardiac tissue - like constructs (CTLCs) by cultivating hiPSC - CMs
on aligned
nanofibers made of biodegradable polymer.
Shuguang Zhang of MIT, who also invented a solar cell based
on spinach, developed the
nanofiber scaffold solution in 1990.
The researchers created a new gel, based
on small molecules which self - assemble into
nanofibers which could interact with a variety of anti-inflammatory, painkiller drugs, including iburofen and naproxen.
Then, one of four other metals (nickel, cobalt, copper, or iron) acts as a scaffold, known as a nucleation site,
on which the
nanofiber continues to grow.
Colonization and osteogenic differentiation of different stem cell sources
on electrospun
nanofiber meshes.
Based
on their discoveries about the feathers» microstructure, the scientists recreated the design in a
nanofiber membrane that could be developed into an ice - proof material, which they say could potentially be used in applications such as electrical insulation.
A LED emitting ultra-violet light is then coated with the DNA
nanofibers: «When UV light is shined
on the material, one dye absorbs the energy and produces blue light.